Bowel stimulators market seen rising to $1.71 billion by 2030

The Business Research Company says the bowel stimulators market will grow from $1.13 billion in 2025 to $1.23 billion in 2026, then reach $1.71 billion by 2030. The report points to rising gastrointestinal disorders, more neurological disease, and wider use of home-based and minimally invasive therapies as the main growth drivers.

Why it matters: - Bowel stimulators are used to help restore bowel function in patients with reduced gastrointestinal motility, including people with spinal cord injuries and chronic constipation. - The devices can reduce reliance on laxatives and manual bowel care, which may improve regularity, comfort and quality of life. - The report frames bowel stimulators as part of a broader shift toward personalized, patient-centered bowel management.

What happened: - The Business Research Company released a market report on bowel stimulators on July 29, 2026. - The report estimates the market will rise from $1.13 billion in 2025 to $1.23 billion in 2026. - The report forecasts the market will reach $1.71 billion by 2030. - The projected 2025-2026 growth rate is 8.8%. - The projected 2026-2030 growth rate is 8.6%. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

The details: - Bowel stimulators send electrical impulses to nerves or muscles to help trigger bowel movements and support peristalsis. - The report links recent growth to limited treatment alternatives for bowel dysfunction, widespread use of laxatives and manual bowel care, rising spinal cord injuries, and an aging population with constipation. - The report also points to broader acceptance of electrical stimulation therapies. - Future growth is expected to come from implantable and external device innovation, higher rates of neurological disorders, and wider adoption of home care and remote therapy. - The report cites improved clinical validation and regulatory approvals as additional support for market expansion. - The report identifies greater use of neuromodulation therapies, wearable and home-based devices, and minimally invasive options as key trends. - The report also expects lower dependence on laxatives and manual interventions, along with better patient awareness and quality-of-life outcomes. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables. - The report is available through a sample download and a full report page: More information and the full report.

Between the lines: - The growth story is being driven less by one breakthrough and more by several converging trends, including demographics, chronic disease burden and broader acceptance of device-based therapy. - The shift toward home care and remote treatment suggests the market is moving beyond specialist settings and into longer-term patient management. - The report’s regional split points to a mature North American market and a faster-expanding Asia-Pacific pipeline.

What's next: - The report expects adoption to keep rising as bowel stimulators become more validated clinically and easier to use outside hospitals. - Market gains will likely depend on whether manufacturers can scale non-invasive and minimally invasive products while meeting regulatory requirements. - The report suggests patient awareness and better outcomes will continue to shape demand through 2030.